Acute Pulmonary Embolism (PE)
- Epidemiology
- Risk Factors for Venous Thromboembolism
- Physiology
- Clinical Decision Rules for the Diagnosis of Acute Pulmonary Embolism
- Clinical Grading/Risk Stratification of Pulmonary Embolism Severity
- Clinical Manifestations
- Prophylaxis
- Treatment
- Pulmonary Embolism Response Team (PERT)
- General Goals of Anticoagulation in Venous Thromboembolism
- Risk Stratification for Anticoagulation-Associated Hemorrhage
- Clinical Features Which May Influence the Choice of Specific Initial/Long-Term Anticoagulants
- Initial Treatment of Venous Thromboembolism (VTE)
- Long-Term Treatment of Venous Thromboembolism (Deep Venous Thrombosis of Acute Pulmonary Embolism) without Cancer
- Long-Term Treatment of Venous Thromboembolism with Cancer
- Specific Duration of Anticoagulation
- Specific Treatment of Acute Pulmonary Embolism with Hypotension (i.e. High-Risk or “Massive” Acute Pulmonary Embolism)
- Specific Treatment of Thrombus in Transit (Clot in Transit)
- Specific Treatment of Asymptomatic Acute Pulmonary Embolism (PE)
- Specific Treatment of Acute Subsegmental Pulmonary Embolism (PE)
- Treatment
- Specific Treatment of Low-Risk Acute Pulmonary Embolism (PE)
- Specific Treatment of Recurrent Venous Thromboembolism (VTE) While Not on Anticoagulation
- Specific Treatment of Recurrent Venous Thromboembolism (VTE) While on Anticoagulation
- Inferior Vena Cava (IVC) Filter Placement
- Specific Treatment of Lower Extremity Deep Venous Thrombosis (DVT)
- Specific Treatment of Lower Extremity Superficial Venous Thrombosis (SVT)
- Specific Treatment of Upper Extremity Deep Venous Thrombosis (DVT)
- Follow-Up of Acute Pulmonary Embolism (PE)
- Prognosis
